Quarterly Results

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1327.25-20.2 (-1.5 %)
PREV CLOSE ( ) 1347.45
OPEN PRICE ( ) 1347.65
BID PRICE (QTY) 1326.10 (2)
OFFER PRICE (QTY) 1328.00 (15)
VOLUME 5249
TODAY'S LOW / HIGH ( )1323.45 1349.00
52 WK LOW / HIGH ( )670 1373.95
NSE1326.00-21.25 (-1.58 %)
PREV CLOSE( ) 1347.25
OPEN PRICE ( ) 1348.95
BID PRICE (QTY) 1325.35 (28)
OFFER PRICE (QTY) 1326.00 (1)
VOLUME 103763
TODAY'S LOW / HIGH( ) 1323.45 1354.00
52 WK LOW / HIGH ( )669.8 1374.6
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
20528.6
20339.6
15875.8
15116.3
Total Expenditure
17215.3
17126.9
12799.6
13305.9
PBIDT (Excl OI)
3313.3
3212.7
3076.2
1810.4
Other Income
224.5
385.5
448.5
363.9
Operating Profit
3537.8
3598.2
3524.7
2174.3
Interest
334
441.2
313.8
184.5
Exceptional Items
680.1
NA
NA
NA
PBDT
3883.9
3157
3210.9
1989.8
Depreciation
995
903.4
692.7
695.4
Profit Before Tax
2888.9
2253.6
2518.2
1294.4
Tax
662.4
879.2
856.1
483.7
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2226.5
1374.4
1662.1
810.69
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
2226.5
1374.4
1662.1
810.69
Minority Interest
-411.2
85.7
-12.8
-16.2
Shares of Associates
-16.5
-9.5
-21.1
-29.3
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1798.8
1450.6
1628.2
765.2
Equity Capital
253.7
253.7
253.7
253.7
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
7.09
5.71
6.41
3.01
Calculated EPS (Annualised)
28.36
22.87
25.67
12.06
No of Public Share Holdings
136271746
136271746
136271746
136271746
% of Public Share Holdings
53.71
53.71
53.7
53.71
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
16.13
15.79
19.37
11.97
PBIDTM%
17.23
17.69
22.20
14.38
PBDTM%
18.91
15.52
20.22
13.16
PBTM%
14.07
11.07
15.86
8.56
PATM%
10.84
6.75
10.46
5.36
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.